SWM
CPRX icon

Spire Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Spire Wealth Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,100
Closed -$306K – 2383
2025
Q2 		$306K Sell
14,100
-4,329
-23% -$102K 0.01% 635
2025
Q1 		$447K Buy
18,429
+4,000
+28% +$90.1K 0.01% 599
2024
Q4 		$301K Buy
14,429
+13,429
+1,343% +$288K 0.01% 705
2024
Q3 		$19.9K Sell
1,000
-38
-4% -$704 ﹤0.01% 1441
2024
Q2 		$16.1K Hold
1,038
– – ﹤0.01% 1514
2024
Q1 		$16.5K Hold
1,038
– – ﹤0.01% 1570
2023
Q4 		$15.1K Hold
1,038
– – ﹤0.01% 1626
2023
Q3 		$12.1K Hold
1,038
– – ﹤0.01% 1668
2023
Q2 		$14K Buy
+1,038
New +$14.9K ﹤0.01% 1711

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return